Protagenic Therapeutics, Inc.\new (PTIX): Total Assets
$3.65M
As of 2026-03-31
$2.80M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $3.65M | n/m | 2026-08-14, Balance as of period end |
| 2025-03-31 | $89.1K | n/a | 2026-08-14, Balance as of period end |
| 2024-12-31 | $1.96M | -54.8% | 2025-03-31, Balance as of period end |
| 2023-12-31 | $4.32M | -46.2% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $8.04M | -27.3% | 2024-05-14, Balance as of period end |
| 2021-12-31 | $11.06M | n/m | 2023-03-31, Balance as of period end |
| 2020-12-31 | $879.2K | +4.4% | 2022-04-07, Balance as of period end |
| 2019-12-31 | $842.3K | +20.9% | 2021-03-25, Balance as of period end |
| 2018-12-31 | $696.9K | -60.9% | 2020-04-29, Balance as of period end |
| 2017-12-31 | $1.78M | -43.7% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $3.16M | n/m | 2018-04-02, Balance as of period end |
| 2015-12-31 | $11.1K | n/a | 2017-05-08, Balance as of period end |
| 2015-06-30 | $133.0K | -45.9% | 2015-09-25, Balance as of period end |
| 2014-06-30 | $246.0K | n/a | 2015-09-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Protagenic Therapeutics, Inc.\new (PTIX) | 2026-03-31 | $3.65M | n/m |
| Bio-Path Holdings, Inc. (BPTH) | 2024-12-31 | $3.88M | +20.6% |
| Pulmatrix, Inc. (PULM) | 2025-12-31 | $4.14M | -58.4% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $4.18M | -52.9% |
| Cadrenal Therapeutics, Inc. (CVKD) | 2025-12-31 | $4.33M | -57.3% |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | $3.07M | +90.2% |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $3.03M | -80.6% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.97M | +7.7% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $2.93M | +9.7% |
Compare PTIX, BPTH, PULM, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗